Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 22nd June, 2024 at the Registered Office of the Company which commenced at 02:00 P.M. and concluded at 02:30 P.M. has considered and approved Allotted 1,13,00,000 (One Crore and Thirteen Lakhs Thousand) fully paid-up Equity shares of face value of Rs. 10.00/- (Rupees Ten Only) per share, at a price of Rs. 17/- (Rupees Seventeen Only) per share, aggregating to Rs. 19,21,00,000/- (Rupees Nineteen Crore Twenty One Lakhs Only) for cash consideration to the person(s)/ entity(ies) belonging to Non-Promoter category on a preferential basis in accordance with provisions of Chapter V of SEBI (ICDR) Regulations, 2018, as mentioned in 'Annexure - I'.

pdf

Evoq Remedies Ltd.

11 Jun 2024

3.15

-1.25%

Company Update

Evoq Remedies Ltd - 543500 - Intimation Of In-Principle Approval Received For Issue And Allotment Upto …

BSE India

Intimation for In-principle Approval

pdf

Evoq Remedies Ltd.

27 May 2024

3.15

-1.25%

Result

Evoq Remedies Ltd - 543500 - Submission Of Audited Financial Results For The Half Year And …

BSE India

Submission of Audited Financial results

pdf

Evoq Remedies Ltd.

27 May 2024

3.15

-1.25%

Board Meeting

Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to Regulations 30 (6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., on 27th May, 2024, at the registered Office of the Company situated at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India - 380060, which commenced at 04:00 P.M. and concluded at 8:00 P.M., inter alia has considered and approved Audited Financial Results of the Company for the Half Year and Year ended on 31st March, 2024 along with Auditors report.

pdf

Evoq Remedies Ltd.

20 May 2024

3.15

-1.25%

Board Meeting

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company will be held on Monday, 27th May, 2024 at 4:00 P.M. at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad - 380060, to consider and approve the Audited Financial Results of the Company for the Half-year and year ended on 31st March, 2024 along with Auditor's Report.

pdf